Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea.
about
Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Circulating autoantibodies aga ...... with obstructive sleep apnea.
@en
Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1
@nl
type
label
Circulating autoantibodies aga ...... with obstructive sleep apnea.
@en
Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1
@nl
prefLabel
Circulating autoantibodies aga ...... with obstructive sleep apnea.
@en
Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1
@nl
P2093
P2860
P1433
P1476
Circulating autoantibodies aga ...... s with obstructive sleep apnea
@en
P2093
Kenji Tsushima
Koichiro Tatsumi
Misuzu Yahaba
Seiichiro Sakao
Takaki Hiwasa
Taku Kinoshita
Takuma Matsumura
Toshinori Ozaki
Yoriko Sakurai
Yoshio Kobayashi
P2860
P304
P356
10.1371/JOURNAL.PONE.0195015
P407
P577
2018-03-29T00:00:00Z